• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Viveve Medical, Inc. - Common Stock (NQ:VIVE)

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EST, Jan 18, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Viveve Medical, Inc. - Common Stock

    < Previous 1 2 Next >
    Viveve to Host Conference Call on August 12, 2021 to Report Second Quarter Financial Results and Provide Corporate Update
    ENGLEWOOD, CO / ACCESSWIRE / August 5, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its second quarter... 
    From Viveve Medical, Inc.
    Via AccessWire
    Viveve Announces Continued Expansion of IP Portfolio with Issuance of Canadian Patent
    ENGLEWOOD, CO / ACCESSWIRE / August 3, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the Canadian Intellectual... 
    From Viveve Medical, Inc.
    Via AccessWire
    Topics Intellectual Property
    Viveve Announces New Category III CPT Code for its Stress Urinary Incontinence Procedure
    New code approved by American Medical Association and supported by key medical societies Long-term pathway for potential reimbursement now established for Company's dual-energy noninvasive treatment... 
    From Viveve Medical, Inc.
    Via AccessWire
    Viveve to Participate in Ladenburg Thalmann Healthcare Virtual Conference
    ENGLEWOOD, CO / ACCESSWIRE / July 6, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive... 
    From Viveve Medical, Inc.
    Via AccessWire
    Viveve Announces Issuance of New Device and Methods Patent in U.S.
    ENGLEWOOD, CO / ACCESSWIRE / June 10, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the United States Patent and... 
    From Viveve Medical, Inc.
    Via AccessWire
    Topics Intellectual Property
    Viveve Announces Adjournment of Annual Meeting
    Meeting scheduled to reconvene June 23, 2021 at 12:00 PM Eastern Time Company encourages stockholders to cast their votes ENGLEWOOD, CO / ACCESSWIRE / June 2, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE),... 
    From Viveve Medical, Inc.
    Via AccessWire
    Viveve Reports First Quarter 2021 Financial Results and Provides Corporate Update
    Pivotal SUI PURSUIT trial enrollment underway and accelerating Total revenue of $1.5M for Q1 including sale of 2,450 consumable treatment tips Strengthened patent portfolio in key Asia Pacific markets... 
    From Viveve Medical, Inc.
    Via AccessWire
    Topics Intellectual Property
    Viveve Announces Adjournment of Annual Meeting
    - Meeting scheduled to reconvene June 2, 2021 at 12:00 PM Eastern Time - Company encourages stockholders to cast their votes ENGLEWOOD, CO / ACCESSWIRE / May 11, 2021 / Viveve Medical, Inc.... 
    From Viveve Medical, Inc.
    Via AccessWire
    Viveve To Host Conference Call on May 13, 2021 To Report First Quarter Financial Results and Provide Corporate Update
    ENGLEWOOD, CO / ACCESSWIRE / May 6, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its first quarter... 
    From Viveve Medical, Inc.
    Via AccessWire
    < Previous 1 2 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.